Search
for
Sort by
Research 31–60 of 129
- Tumour regression predicts higher risk of sentinel node involvement in thin cutaneous melanomas
- Adverse Cutaneous Reactions to Antipsychotics
- REVIEW OF SO-CALLED ASEPTIC NEUTROPHILIC DERMATOSES
- Psychoactive drugs and skin
- Dermatological manifestations associated with COVID‐19: A comprehensive review of the current knowledge
- Cutaneous manifestations of systemic infection in children
- Urticaria, Drug Hypersensitivity Rashes, Nodules and Tumors, and Atrophic Diseases
- Skin manifestations associated with COVID-19
- Cutaneous Adverse Drug Reactions (CADRs) to COVID19 vaccines: A case series
- Cutaneous manifestations associated with substance use disorders
- Drug-Induced Skin, Nail and Hair Disorders
- Adverse Cutaneous Reactions to Mood Stabilizers
- Adverse Cutaneous Reactions to Antidepressants
- Toxic shock syndrome: Recent developments in pathogenesis
- Adverse cutaneous effects of psychotropic medications
- Multiple skin cancers in a patient within 1 year of allogeneic haematopoietic cell transplant for chronic lymphocytic leukaemia
- Index
- Cutaneous effects of the most commonly used antidepressant medication, the selective serotonin reuptake inhibitors
- Adverse cutaneous reactions to chemotherapeutic agents and cytokine therapy
- Drug eruptions in dermatology
- Actinic superficial folliculitis
- Dermatologic Conditions of the Early Post-Transplant Period in Hematopoietic Stem Cell Transplant Recipients
- The spectrum of nephrocutaneous diseases and associations
- Benefit-Risk Assessment of GLP-1 Receptor Agonists: Implications for Dermatologists and Plastic Surgeons
- Skin Manifestations in Confirmed COVID 19 Patients; A Short Prospective Multicenter Case Series Cohort Study
- Dermatologic Side Effects of Systemic Targeted Anticancer Therapy
- Cutaneous manifestations of COVID-19 and vaccines for its prevention: a review of the existing literature
- Mucocutaneous reactions to chemotherapy
- Lupus erythematosus: systemic and cutaneous manifestations
- Dermatological adverse events with taxane chemotherapy